Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.070
0.00 (0.00%)
Nov 6, 2026, 4:00 PM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $51.82 million as of November 9, 2026. It is the 29,573rd most valuable company in the world and the 4,546th biggest in the United States. Its market cap has decreased by 54.13% in one year.
Market Cap
51.82M
Enterprise Value
53.19M
Revenue
5.20M
Global Rank
Country Rank
#4,546 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 51.82M, an increase of 161.02%. That is a compound annual growth rate of 10.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 51.82M | -45.40% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 92.36M |
| Vaxart | 89.98M |
| ProText Mobility | 66.81M |
| Sangamo Therapeutics | 47.23M |
| Arch Biopartners | 42.12M |
| Cell Source | 35.80M |
| ZIVO Bioscience | 33.71M |
| Provectus Biopharmaceuticals | 22.27M |